Comprehensive analysis of Bandhan BSE Healthcare Index Fund - Regular (G) (45047) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
Bandhan Asset Management Company Ltd
The investment objective of the Scheme is to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors. However, there is no assurance or guarantee that the objectives of the scheme will be realized and the scheme does not assure or guarantee any returns.
A comprehensive at-a-glance view of key mutual fund health indicators
Weak Returns
High Risk
Moderate Expenses
Equity Focused
New Team
Below Average
Showing 1Y NAV history
Performance across different time periods
Fund shows concerning indicators. Exercise caution before investing.
Consider waiting for better market conditions or explore alternatives.
Fund shows concerning indicators. Exercise caution before investing.
Consider waiting for better market conditions or explore alternatives.
Recent performance momentum
Market exposure level
Outperformance vs benchmark
Fund management costs
Risk-adjusted returns
Fund manager experience
Historical performance consistency
Assets under management
This fund has underperformed its benchmark by 48.32% over the 3Y period.
See how your money can grow and compare with popular investment options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
| Company | Sector | % Assets |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals | 13.39% |
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals | 13.34% |
| Max Healthcare Institute Ltd | Healthcare | 7.10% |
| Max Healthcare Institute Ltd | Healthcare | 6.83% |
| Cipla Ltd | Pharmaceuticals | 6.54% |
| Divis Laboratories Ltd | Pharmaceuticals | 6.54% |
| Cipla Ltd | Pharmaceuticals | 6.41% |
| Divis Laboratories Ltd | Pharmaceuticals | 6.26% |
| Dr Reddys Laboratories Ltd | Pharmaceuticals | 5.89% |
| Dr Reddys Laboratories Ltd | Pharmaceuticals | 5.76% |
Compare against Index Fund category average
This comparison shows how the fund performs relative to the Index Fund category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Index Fund category
| Fund Name | NAV | 1M | 3M | 6M |
|---|---|---|---|---|
| Invesco India Nifty G-sec Sep 2032 Index Fund-Dir (IDCW) | ₹1233.29 | -0.46% | 2.98% | 6.17% |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Dir (G) | ₹1233.29 | -0.46% | 2.98% | 6.17% |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Reg (G) | ₹1229.16 | -0.47% | 2.94% | 6.09% |
| Invesco India Nifty G-sec Sep 2032 Index Fund-Reg (IDCW) | ₹1229.15 | -0.47% | 2.94% | 6.09% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Dir (G) | ₹1199.62 | 0.40% | 2.73% | 4.94% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Dir (IDCW | ₹1199.62 | 0.40% | 2.73% | 4.94% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Reg (IDCW) | ₹1195.53 | 0.38% | 2.69% | 4.86% |
| Invesco India Nifty G-sec Jul 2027 Index Fund-Reg (G) | ₹1195.51 | 0.38% | 2.69% | 4.86% |
| HDFC BSE Sensex Index Fund - Direct | ₹790.24 | 3.06% | 10.66% | 7.25% |
| HDFC BSE Sensex Index Fund - Regular | ₹771.61 | 3.04% | 10.61% | 7.17% |
A seasoned investment professional with over 1 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.